全球狂犬病诊断市场规模、份额、趋势和成长分析报告（2026-2034年）

狂犬病诊断市场预计将从 2025 年的 27 亿美元成长到 2034 年的 40 亿美元，2026 年至 2034 年的复合年增长率为 4.44%。

由于狂犬病在发展中地区持续蔓延，全球狂犬病诊断市场正稳定成长。各国主导加强根除狂犬病，推动了对诊断检测的需求。早期准确检测对于有效控制和预防疾病至关重要。兽医基础设施的扩建促进了市场成长。疫苗接种和检测宣传活动的加强提高了筛检率。分子诊断技术的进步提高了检测的准确性。全球为实现狂犬病零死亡所做的努力也支撑了市场的未来发展前景。

另一个重要的驱动因素是快速诊断试剂盒在农村和偏远地区的广泛应用。就地检验解决方案提高了检测的可及性，并缩短了检测结果的获取时间。世界卫生组织正在资助地方性流行国家的狂犬病监测计画。某些地区流浪动物数量的增加提高了检测需求。研究机构正致力于开发经济高效的携带式检测设备。公私合营正在加强分销网络。 PCR和免疫检测技术的进步将在预测期内加速成长。

此外，全球兽医诊断和检测能力的提升正在影响市场。伴侣动物医疗费用支出的增加推动了对常规体检的需求。低温运输物流的改善促进了诊断剂的配送。监管机构正致力于推广标准化诊断通讯协定，以确保其可靠性。政府与非政府组织之间合作的加强正在改善疾病监测系统。生技公司正投资开发创新检测方法。从长远来看，综合监测系统和数位化报告平台将进一步提升狂犬病诊断市场的前景。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球狂犬病诊断市场：依诊断方法划分

• 市场分析、洞察与预测
• 萤光测定法（FAT）
• 免疫组织化学检查
• 扩增方法
• 组织学检查
• 血清学检测

第五章 全球狂犬病诊断市场：依技术与方法划分

• 市场分析、洞察与预测
• 酵素连结免疫吸附试验/免疫组织化学
• 层析法技术
• PCR
• 其他的

第六章 全球狂犬病诊断市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Bio-Rad Laboratories Inc
  • Aviva Systems Biology Corporation
  • Merck KGaA
  • Demeditec Diagnostics GmbH
  • Creative Diagnostics
  • Norgen Biotek Corp
  • Abbexa Ltd
  • Express Biotech International Inc
  • BioNote Inc
  • MyBioSource.Com

The Rabies Diagnostics Market size is expected to reach USD 4.00 Billion in 2034 from USD 2.70 Billion (2025) growing at a CAGR of 4.44% during 2026-2034.

The Global Rabies Diagnostics Market is growing steadily due to the continued prevalence of rabies in developing regions. Increasing government initiatives aimed at rabies elimination are driving diagnostic testing demand. Early and accurate detection is critical for effective disease management and prevention. The expansion of veterinary healthcare infrastructure is contributing to market growth. Rising awareness campaigns regarding vaccination and testing are increasing screening rates. Technological advancements in molecular diagnostic techniques are improving accuracy. Future prospects are supported by global efforts to achieve zero rabies deaths.

Another significant driver is the increasing adoption of rapid diagnostic kits in rural and remote areas. Point-of-care testing solutions are enhancing accessibility and reducing turnaround time. International health organizations are funding rabies surveillance programs in endemic countries. The growing population of stray animals in certain regions is increasing testing requirements. Research institutions are focusing on developing cost-effective and portable testing devices. Public-private partnerships are strengthening distribution networks. Over the forecast period, advancements in PCR-based and immunoassay technologies will accelerate growth.

The market is also influenced by expanding veterinary diagnostics and laboratory capabilities worldwide. Companion animal healthcare expenditure is rising, boosting routine testing demand. Improved cold chain logistics are supporting distribution of diagnostic reagents. Regulatory agencies are promoting standardized diagnostic protocols to ensure reliability. Increasing collaboration between governments and NGOs is improving disease monitoring systems. Biotechnology companies are investing in innovative assay development. In the long term, integrated surveillance systems and digital reporting platforms will further enhance the rabies diagnostics market outlook.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Diagnostic Method

• Fluorescent Antibody Test (FAT)
• Immunohistochemical Test
• Amplification Methods
• Histologic Examination
• Serology Tests

By Technology Method

• ELISA/Immunohistochemistry
• Chromatography Techniques
• PCR
• Others

COMPANIES PROFILED

• BioRad Laboratories Inc, Aviva Systems Biology Corporation, Merck KGaA, Demeditec Diagnostics GmbH, Creative Diagnostics, Norgen Biotek Corp, Abbexa Ltd, Express Biotech International Inc, BioNote Inc, MyBioSourcecom
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL RABIES DIAGNOSTICS MARKET: BY DIAGNOSTIC METHOD 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Diagnostic Method
• 4.2. Fluorescent Antibody Test (FAT) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Immunohistochemical Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Amplification Methods Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Histologic Examination Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Serology Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL RABIES DIAGNOSTICS MARKET: BY TECHNOLOGY METHOD 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology Method
• 5.2. ELISA/Immunohistochemistry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Chromatography Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. PCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL RABIES DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Diagnostic Method
  • 6.2.2 By Technology Method
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Diagnostic Method
  • 6.3.2 By Technology Method
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Diagnostic Method
  • 6.4.2 By Technology Method
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Diagnostic Method
  • 6.5.2 By Technology Method
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Diagnostic Method
  • 6.6.2 By Technology Method
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL RABIES DIAGNOSTICS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Bio-Rad Laboratories Inc
  • 8.2.2 Aviva Systems Biology Corporation
  • 8.2.3 Merck KGaA
  • 8.2.4 Demeditec Diagnostics GmbH
  • 8.2.5 Creative Diagnostics
  • 8.2.6 Norgen Biotek Corp
  • 8.2.7 Abbexa Ltd
  • 8.2.8 Express Biotech International Inc
  • 8.2.9 BioNote Inc
  • 8.2.10 MyBioSource.Com